Serveur d'exploration sur la rapamycine et les champignons - Curation (Accueil)

Index « MedMesh.i » - entrée « Hepacivirus »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hep G2 Cells < Hepacivirus < Hepatic Stellate Cells  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]
Ident.Authors (with country if any)Title
000147 (2020) Manish Kumar Johri [Inde] ; Hiren Vasantrai Lashkari [Inde] ; Divya Gupta [Inde] ; Dhiviya Vedagiri [Inde] ; Krishnan Harinivas Harshan [Inde]mTORC1 restricts hepatitis C virus RNA replication through ULK1-mediated suppression of miR-122 and facilitates post-replication events.
000192 (2019) Mei-Yueh Lee [Taïwan] ; Wei-Chun Chen [Taïwan] ; Wei-Hao Hsu [Taïwan] ; Szu-Chia Chen [Taïwan] ; Jin-Ching Lee [Taïwan]Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism.
000195 (2019) Hanzada Mohamed El Maghrabi [Égypte] ; Ahmed Yahia Elmowafy [Égypte] ; Ayman Fathi Refaie [Égypte] ; Mohammed Adel Elbasiony [Égypte] ; Gamal Elsayed Shiha [Égypte] ; Lionel Rostaing [France] ; Mohamed Adel Bakr [Égypte]Efficacy and safety of the new antiviral agents for the treatment of hepatitis C virus infection in Egyptian renal transplant recipients.
000353 (2019) Di Dem Özer Etik [Turquie] ; Nuretdin Suna ; Serkan Öcal ; Haldun Selçuk ; Ülkü Da L ; Turan Çolak ; Fatih Hilmio Lu ; Ahmet Sedat Boyac O Lu ; Mehmet HaberalSuccessful Treatment With Direct-Acting Antiviral Agents of Hepatitis C in Patients With End-Stage Renal Disease and Kidney Transplant Recipients.
000425 (2018) Ngan N T. Nguyen [Corée du Sud] ; Yun-Sook Lim [Corée du Sud] ; Lap P. Nguyen [Corée du Sud] ; Si C. Tran [Corée du Sud] ; Trang T D. Luong [Corée du Sud] ; Tram T T. Nguyen [Corée du Sud] ; Hang T. Pham [Corée du Sud] ; Han N. Mai [Corée du Sud] ; Jae-Woong Choi [Corée du Sud] ; Sang-Seop Han [Corée du Sud] ; Soon B. Hwang [Corée du Sud]Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
000576 (2018) A. Weigert [Portugal] ; S. Querido [Portugal] ; L. Carvalho [Portugal] ; L. Lebre [Portugal] ; C. Chagas [Portugal] ; P. Matias [Portugal] ; R. Birne [Portugal] ; C. Nascimento [Portugal] ; C. Jorge [Portugal] ; T. Adragão [Portugal] ; M. Bruges [Portugal] ; D. Machado [Portugal]Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal.
000625 (2018) José A. Del Campo [Espagne] ; Marta García-Valdecasas [Espagne] ; Antonio Gil-G Mez [Espagne] ; Ángela Rojas [Espagne] ; Paloma Gallego [Espagne] ; Javier Ampuero [Espagne] ; Rocío Gallego-Durán [Espagne] ; Helena Pastor [Espagne] ; Lourdes Grande [Espagne] ; Francisco J. Padillo [Espagne] ; Jordi Muntané [Espagne] ; Manuel Romero-G Mez [Espagne]Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.
000725 (2017) A. Frey [Allemagne] ; E-M Ecker [Allemagne] ; K. Piras-Straub [Allemagne] ; A. Walker [Allemagne] ; T G Hofmann [Allemagne] ; J. Timm [Allemagne] ; B B Singer [Allemagne] ; G. Gerken [Allemagne] ; K. Herzer [Allemagne]Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
000795 (2017) Ayesha Khalid [Pakistan] ; Tabinda Hussain [Pakistan] ; Sobia Manzoor [Pakistan] ; Muhammad Saalim [Pakistan] ; Saba Khaliq [Pakistan]PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma.
000922 (2016) Wei-Liang Liu [Taïwan] ; Hung-Chih Yang [Taïwan] ; Ching-Sheng Hsu [Taïwan] ; Chih-Chiang Wang [Taïwan] ; Tzu-San Wang [Taïwan] ; Jia-Horng Kao [Taïwan] ; Ding-Shinn Chen [Taïwan]Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.
000B15 (2016) Celeste C. Goh [États-Unis] ; Krystal M. Roggerson [États-Unis] ; Hai-Chon Lee ; Lucy Golden-Mason [États-Unis] ; Hugo R. Rosen [États-Unis] ; Young S. Hahn [États-Unis]Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.
000B17 (2016) Ming-Ling Chang [Taïwan]Metabolic alterations and hepatitis C: From bench to bedside.
000D05 (2015) Mohamed H. Abbas [Égypte] ; Mabrouk I. Ismail ; Salem A. El Deeb ; Ayman M. Nagib ; Nabil M. Hassan ; Ayman F. Refaie ; Hanzada M. El Maghrabi ; Ahmed A. Denewar ; Mohamed A. BakrEffect of pretransplant hepatitis C virus on the development of new-onset diabetes mellitus after transplant in Egyptian living-donor renal allotransplant recipients at Mansoura Urology and Nephrology Center.
000D89 (2015) Faouzi Saliba [France] ; Frederik NevensProgression of liver fibrosis in HCV-positive liver transplant recipients randomized to everolimus with reduced calcineurin inhibitor (CNI) therapy or a standard CNI regimen.
000E27 (2014) Ozan Yazici [Turquie] ; Mehmet Ali Nahit Sendur [Turquie] ; Sercan Aksoy [Turquie]Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.
000F45 (2013) Amin Soliman [Égypte] ; Ahmed Fathy ; Sahier Khashab ; Noha Shaheen ; Mahmoud SolimanSirolimus conversion may suppress viral replication in hepatitis C virus-positive renal transplant candidates.
000F91 (2013) Hui Chen [République populaire de Chine] ; Li Ye ; Jin-Ming Su ; Yu Li ; Jin-Rong Zeng ; Wen-Zhe Huo[Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
001086 (2013) He Huang [République populaire de Chine] ; Rongyan Kang ; Ji Wang ; Guangxiang Luo ; Wei Yang ; Zhendong ZhaoHepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy.
001113 (2012) Audrey Coilly [France] ; Valérie Furlan ; Bruno Roche ; Caroline Barau ; Coralie Noël ; Laurence Bonhomme-Faivre ; Teresa Maria Antonini ; Anne-Marie Roque-Afonso ; Didier Samuel ; Anne-Marie Taburet ; Jean-Charles Duclos-ValléePractical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.
001134 (2012) Li Ye [République populaire de Chine] ; Jieliang Li ; Ting Zhang ; Xu Wang ; Yizhong Wang ; Yu Zhou ; Jinping Liu ; Hemant K. Parekh ; Wenzhe HoMycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells.
001140 (2012) Shubham Shrivastava [États-Unis] ; Joydip Bhanja Chowdhury ; Robert Steele ; Ranjit Ray ; Ratna B. RayHepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Hepacivirus" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Hepacivirus" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Hepacivirus
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020